Prasad et al. reported that activation of the UPR in melanoma, specifically IRE1 and XBP1, prior to the introduction of oncolytic viruses enhanced adenovirus levels specifically in cancerous cells and resulted in increased tumour cell killing [146]. The gene discussed is XBP1; the disease is neoplasm.